Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

BRENT ANDREW FLICKINGER

Allopathic & Osteopathic Physicians Internal Medicine Rheumatology

NPI
1902914872
CMS profile
359488
Location
GAINESVILLE, GA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2023 · Entire year

$3,900.46

214 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2023 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $3,900.46 214

By paying entity

PY2023 · entire year · sorted by reported total

Page 4 of 5; records 151–200 of 214 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

BRENT ANDREW FLICKINGER

NPI 1902914872 · CMS profile ID 359488

Allopathic & Osteopathic Physicians / Internal Medicine / Rheumatology

GAINESVILLE, GA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 4 of 5; records 151–200 of 214 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1902914872?year=2023&recipient=provider&page=4#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
BRENT ANDREW FLICKINGER, NPI 1902914872, CMS profile ID 359488. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 4 of 5; records 151–200 of 214 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1902914872?year=2023&recipient=provider&page=4#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
APA 7
IndustryPayments. (2026). BRENT ANDREW FLICKINGER, NPI 1902914872, CMS profile ID 359488. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 4 of 5; records 151–200 of 214 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1902914872?year=2023&recipient=provider&page=4#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
Bluebook
BRENT ANDREW FLICKINGER, NPI 1902914872, CMS profile ID 359488, IndustryPayments, General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 4 of 5; records 151–200 of 214 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9. https://industrypayments.org/provider/npi-1902914872?year=2023&recipient=provider&page=4#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30

214 matching records · $3,900.46 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 214 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 151–200 of 214.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Fresenius Kabi USA, LLC $13.2004/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1060084509 CMS
Amgen Inc. $15.3404/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1019838719 CMS
Radius Health, Inc. $30.8004/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1024683331 CMS
Amgen Inc. $33.7404/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1019838705 CMS
Amgen Inc. $28.2504/05/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1019838701 CMS
ABBVIE INC. $27.5904/04/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997259953 CMS
ABBVIE INC. $17.3904/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997259951 CMS
UCB, Inc. $17.2803/31/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1021486533 CMS
ABBVIE INC. $28.5603/30/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997259949 CMS
AstraZeneca Pharmaceuticals LP $20.5703/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1011878233 CMS
GENZYME CORPORATION $16.2003/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049965405 CMS
ABBVIE INC. $33.7303/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997259947 CMS
Amgen Inc. $7.4203/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1019838717 CMS
Amgen Inc. $20.3503/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1020545563 CMS
PFIZER INC. $28.9703/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050388761 CMS
ABBVIE INC. $9.9003/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997259945 CMS
GENZYME CORPORATION $19.4903/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049965409 CMS
Amgen Inc. $25.0403/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1019838737 CMS
UCB, Inc. $17.8603/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1021486557 CMS
E.R. Squibb & Sons, L.L.C. $22.6603/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015636703 CMS
Amgen Inc. $22.6603/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1019838731 CMS
UCB, Inc. $18.5403/09/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1021486573 CMS
Genentech USA, Inc. $23.5503/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040315615 CMS
Novartis Pharmaceuticals Corporation $10.1103/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 991681673 CMS
ABBVIE INC. $24.2303/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997259943 CMS
ABBVIE INC. $19.8803/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997259941 CMS
UCB, Inc. $17.3103/05/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1021486541 CMS
AstraZeneca Pharmaceuticals LP $23.8103/02/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015708085 CMS
ABBVIE INC. $20.7002/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997259939 CMS
Janssen Biotech, Inc. $16.9702/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988370947 CMS
Amgen Inc. $28.5602/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1019838713 CMS
Horizon Therapeutics plc $24.7402/24/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 986998013 CMS
UCB, Inc. $19.7502/24/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1021479113 CMS
ABBVIE INC. $30.8002/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997259937 CMS
ABBVIE INC. $14.9902/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997259935 CMS
PFIZER INC. $18.2402/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050685949 CMS
E.R. Squibb & Sons, L.L.C. $22.6602/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015636643 CMS
ABBVIE INC. $24.3402/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997259933 CMS
Horizon Therapeutics plc $25.0102/09/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 986998009 CMS
Horizon Therapeutics plc $26.0002/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 986998005 CMS
Janssen Biotech, Inc. $16.9702/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988370957 CMS
UCB, Inc. $20.0302/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1021479117 CMS
Novartis Pharmaceuticals Corporation $21.7802/02/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 991681661 CMS
ABBVIE INC. $24.6502/01/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997259931 CMS
Amgen Inc. $22.3602/01/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1020545561 CMS
PFIZER INC. $18.2401/31/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050633019 CMS
ABBVIE INC. $20.8901/30/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997259929 CMS
GlaxoSmithKline, LLC. $18.9501/26/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1002139501 CMS
Novartis Pharmaceuticals Corporation $22.0701/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 991681657 CMS
Genentech USA, Inc. $23.5501/24/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040315611 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $2,437.89 165
PY2020 $818.10 59
PY2021 $2,177.43 144
PY2022 $3,490.82 198
PY2023 $3,900.46 214
PY2024 $4,047.99 210
PY2025 $3,607.45 181

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $236,815.29 9
PY2024 Principal investigator $932,747.96 7
PY2023 Principal investigator $153,394.04 14
PY2022 Principal investigator $268,839.16 14
PY2021 Principal investigator $9,261.36 3

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

9 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Novartis Pharmaceuticals Corporation $81,873.64 11/15/2025 Non-covered Recipient Entity
ARTHRITIS CENTER OF NORTH GEORGIA
A Randomized, Parallel-group, Double-blind, Placebo-controlled, Multicenter Phase III Trial to Evaluate Efficacy and Safety of Secukinumab Administered Subcutaneously Versus Placebo, in Combination With a Glucocorticoid Taper Regimen, in Patients With Pol No dispute reported 06/30/2026 1190313345
Principal investigator 1 Aurinia Pharma U.S., Inc. $7,500.00 11/05/2025 Non-covered Recipient Entity
Southeastern Rheumatology Alliance dba Arthritis C
LUPKYNIS Registry Study No dispute reported 06/30/2026 1243931086
Principal investigator 1 UCB SA $14,608.00 10/03/2025 Non-covered Recipient Entity
Southeastern Rheumatology Alliance
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY AND SAFETY OF DAPIROLIZUMAB PEGOL IN STUDY PARTICIPANTS WITH MODERATELY TO SEVERELY ACTIVE SYSTEMIC LUPUS ERYTHEMATOSUS No dispute reported 06/30/2026 1246658062
Principal investigator 1 Amgen Inc. $27,100.00 09/19/2025 Non-covered Recipient Entity
SOUTHEASTERN RHEUMATOLOGY ALLIANCE
A study to Evaluate the Efficacy and Safety of Dosing KRYSTEXXA (pegloticase) + MTX in Participants No dispute reported 06/30/2026 1246648401
Principal investigator 1 UCB SA $125.00 08/22/2025 Non-covered Recipient Entity
ARTHRITIS CENTER OF NORTH GEORGIA
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY AND SAFETY OF DAPIROLIZUMAB PEGOL IN STUDY PARTICIPANTS WITH MODERATELY TO SEVERELY ACTIVE SYSTEMIC LUPUS ERYTHEMATOSUS No dispute reported 06/30/2026 1246656587
Principal investigator 1 Aurinia Pharma U.S., Inc. $1,215.00 03/26/2025 Non-covered Recipient Entity
Southeastern Rheumatology Alliance dba Arthritis C
LUPKYNIS Registry Study No dispute reported 06/30/2026 1243930882
Principal investigator 1 Novartis Pharmaceuticals Corporation $74,372.27 01/28/2025 Non-covered Recipient Entity
ARTHRITIS CENTER OF NORTH GEORGIA
A Multi-center, Open-label Extension Study of Subcutaneous Secukinumab to Evaluate the Long-term Safety and Tolerability in Polymyalgia Rheumatica (PMR) No dispute reported 06/30/2026 1190313347
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $17,360.31 01/21/2025 Non-covered Recipient Entity
Arthritis Center Of North Georgia
A Study to Determine the Efficacy and Safety of Deucravacitinib Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Are Nave to Biologic Disease-modifying Anti-rheumatic Drugs No dispute reported 06/30/2026 1235998880
Principal investigator 1 UCB SA $12,661.07 01/21/2025 Non-covered Recipient Entity
ARTHRITIS CENTER OF NORTH GEORGIA LLC
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY AND SAFETY OF DAPIROLIZUMAB PEGOL IN STUDY PARTICIPANTS WITH MODERATELY TO SEVERELY ACTIVE SYSTEMIC LUPUS ERYTHEMATOSUS No dispute reported 06/30/2026 1246657448